Seidel, S.; Nilius-Eliliwi, V.; Kowalski, T.; Vangala, D.B.; Schlegel, U.; Schroers, R.
High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Primary CNS Lymphoma: A Retrospective Monocentric Analysis of Long-Term Outcome, Prognostic Factors, and Toxicity. Cancers 2022, 14, 2100.
https://doi.org/10.3390/cancers14092100
AMA Style
Seidel S, Nilius-Eliliwi V, Kowalski T, Vangala DB, Schlegel U, Schroers R.
High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Primary CNS Lymphoma: A Retrospective Monocentric Analysis of Long-Term Outcome, Prognostic Factors, and Toxicity. Cancers. 2022; 14(9):2100.
https://doi.org/10.3390/cancers14092100
Chicago/Turabian Style
Seidel, Sabine, Verena Nilius-Eliliwi, Thomas Kowalski, Deepak Ben Vangala, Uwe Schlegel, and Roland Schroers.
2022. "High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Primary CNS Lymphoma: A Retrospective Monocentric Analysis of Long-Term Outcome, Prognostic Factors, and Toxicity" Cancers 14, no. 9: 2100.
https://doi.org/10.3390/cancers14092100
APA Style
Seidel, S., Nilius-Eliliwi, V., Kowalski, T., Vangala, D. B., Schlegel, U., & Schroers, R.
(2022). High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Primary CNS Lymphoma: A Retrospective Monocentric Analysis of Long-Term Outcome, Prognostic Factors, and Toxicity. Cancers, 14(9), 2100.
https://doi.org/10.3390/cancers14092100
